Table 3.
Cancer | Group | IRR point estimates |
p-value | |
---|---|---|---|---|
Race vs. White (β4) | Time*race interaction (β5) | |||
Breast | Latinx | 0.845 | 1.008 | 0.176 |
Breast | Asian | 0.819 | 0.998 | <0.001 |
Breast | Black | 0.985 | 0.978 | 0.099 |
Breast | Overall | – | – | <0.001 |
Cervical | Latinx | 1.124 | 0.982 | 0.246 |
Cervical | Asian | 0.989 | 0.993 | 0.508 |
Cervical | Black | 1.027 | 0.985 | 0.292 |
Cervical | Overall | – | – | 0.494 |
Colorectal | Latinx | 0.772 | 1.028 | 0.156 |
Colorectal | Asian | 1.056 | 0.986 | 0.794 |
Colorectal | Black | 1.026 | 0.990 | 0.713 |
Colorectal | Overall | – | – | 0.58 |
Lung | Latinx | 0.521 | 1.013 | <0.001 |
Lung | Asian | 1.152 | 0.945 | 0.098 |
Lung | Black | 0.591 | 1.055 | 0.02 |
Lung | Overall | – | – | <0.001 |
[1] Wald p-value based on testing for joint null hypothesis for beta4 = beta5 = 0 (for each race and for all races in overall)
[2] Race vs. White IRR estimates refer to rates of screening in April 2019
[3] Time* Race interaction refer to the ratio of year-to-year OR for each race relative to white